| Phone Icon 403.210.5275 | Email Icon Contact Us | Resize Text
Post Header Graphic
Category:

National initiative will start to bring precision health to patients

In Boston this morning as part of the BIO 2018 Conference and Exhibition, Genome Canada launched a national initiative for the clinical implementation of precision health. The initial step will be focused on a rare disease pilot program.
It may seem as a bit of an oxymoron but rare diseases are not uncommon. With more than 7,000 different rare diseases known, the total number of patients starts to add up. In Canada, 8 per cent of Canadians have a rare disease.
Genomics-based precision health holds the promise of improving patient health and improving the delivery of health-care delivery and the new Genome Canada pilot will focus on rare diseases as another step to making the promise a reality for patient.
Genome Canada CEO and President Marc LePage made the announcement during a panel session at BIO 2018 and he told me more about the new program.

National initiative will start to bring precision health to patients

Listen Icon Listen to podcast

Chat Icon